Blueprint Medicines, CoreWeave, Inc. Class A Common Stock, Applied Digital, ProShares UltraPro Short QQQ, and Tempus AI are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear undervalued by the market relative to their underlying fundamentals—such as earnings, book value or cash flow. They typically trade at low price-to-earnings or price-to-book multiples and often offer above-average dividend yields. Investors buy value stocks in the expectation that the market will eventually recognize their true worth, driving share prices upward over time. These companies had the highest dollar trading volume of any Value stocks within the last several days.
Blueprint Medicines (BPMC)
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.
Shares of Blueprint Medicines stock traded up $26.19 during trading on Monday, hitting $127.54. 41,217,894 shares of the company's stock traded hands, compared to its average volume of 955,169. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.85 and a quick ratio of 2.80. The stock has a market capitalization of $8.24 billion, a P/E ratio of -118.08 and a beta of 0.83. The business has a 50-day simple moving average of $91.67 and a 200-day simple moving average of $94.66. Blueprint Medicines has a 1 year low of $73.04 and a 1 year high of $128.54.
Read Our Latest Research Report on BPMC
CoreWeave, Inc. Class A Common Stock (CRWV)
Shares of NASDAQ CRWV traded up $6.93 during trading on Monday, reaching $118.24. 22,453,508 shares of the company traded hands, compared to its average volume of 19,314,391. The firm's 50 day moving average price is $60.06. CoreWeave, Inc. Class A Common Stock has a 52-week low of $33.51 and a 52-week high of $130.76.
Read Our Latest Research Report on CRWV
Applied Digital (APLD)
Applied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services.
Applied Digital stock traded up $3.44 during midday trading on Monday, reaching $10.27. 211,343,916 shares of the company traded hands, compared to its average volume of 32,174,268. The company has a debt-to-equity ratio of 1.22, a current ratio of 0.77 and a quick ratio of 0.77. Applied Digital has a 12 month low of $3.01 and a 12 month high of $12.48. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of -5.94 and a beta of 5.98. The business has a 50 day moving average of $5.54 and a two-hundred day moving average of $7.40.
Read Our Latest Research Report on APLD
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Shares of NASDAQ SQQQ traded down $0.51 during midday trading on Monday, hitting $23.22. 76,190,185 shares of the stock traded hands, compared to its average volume of 58,372,191. ProShares UltraPro Short QQQ has a one year low of $22.69 and a one year high of $57.95. The firm has a 50-day moving average of $32.78 and a two-hundred day moving average of $31.67.
Read Our Latest Research Report on SQQQ
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Tempus AI stock traded up $8.47 during mid-day trading on Monday, reaching $63.65. 27,667,837 shares of the stock traded hands, compared to its average volume of 6,766,037. Tempus AI has a 12-month low of $22.89 and a 12-month high of $91.45. The business's 50-day moving average is $52.07 and its 200-day moving average is $51.75. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock has a market capitalization of $11.02 billion and a PE ratio of -8.13.
Read Our Latest Research Report on TEM
See Also
Before you consider Blueprint Medicines, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blueprint Medicines wasn't on the list.
While Blueprint Medicines currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
